The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 13,603 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 15,639 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| AMGEN INC | COM | 031162100 | 13,832 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| AMGEN INC | COM | 031162100 | 20,748 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 10,532 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| CYPRESS SEMICONDUCTOR CORP | COM | 232806109 | 9,372 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| GW PHARMACEUTICALS PLC | ADS | 36197T103 | 10,964 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| KITE PHARMA INC | COM | 49803L109 | 3,530 | 63,400 | SH | Call | SOLE | 63,400 | 0 | 0 | |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 17,340 | 1,233,285 | SH | SOLE | 1,233,285 | 0 | 0 | ||
| ORACLE CORP | COM | 68389X105 | 18,060 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |